365mc, a leading fat reduction provider in South Korea, has announced plans to open a clinic in Los Angeles in September. They are also establishing a strategic partnership with Raziel Therapeutics, a biotechnology company, to develop next-generation fat reduction technology in South Korea.
![]() |
Dr. Kim Nam-Chul and a Raziel Therapeutics representative at the signing ceremony. Photo: 365mc |
Dr. Kim Nam-Chul and a Raziel Therapeutics representative at the signing ceremony. Photo: 365mc
The US clinic will utilize LAMS (Liposuction Assisted Modeling System), a minimally invasive liposuction technique developed by 365mc. This technology integrates artificial intelligence (AI) throughout the entire process, delivering effective results without surgery. This expansion marks a significant step in 365mc's global strategy, following successful expansions into Indonesia and Thailand in 2024.
Following the Los Angeles launch, 365mc will open a second branch in Phuket, Thailand, furthering the brand's global expansion.
![]() |
365mc's CEO at the opening ceremony in Thailand. Photo: 365mc |
365mc's CEO at the opening ceremony in Thailand. Photo: 365mc
365mc is currently the largest fat reduction treatment network in South Korea, with 21 medical facilities across various cities. The company has developed a specialized treatment model that combines liposuction, nutritional counseling, behavioral therapy, and long-term monitoring. This approach aims to provide sustainable, safe results that meet the beauty needs of a new generation.
In addition to expanding into the US, 365mc has announced a strategic partnership with Raziel Therapeutics, an Israeli biopharmaceutical company developing RZL-012. RZL-012 is an injectable compound capable of destroying localized fat cells without surgical intervention. This therapy is currently entering its final clinical trial phase (Phase 3). The two companies will collaborate to conduct RZL-012 trials in South Korea and develop a treatment protocol combining the injectable compound with LAMS technology. This collaboration lays the groundwork for a new generation of non-invasive, scalpel-free body contouring.
![]() |
To be certified in LAMS, doctors from Vietnam, Thailand, the US, and other countries must complete training in South Korea. Photo: 365mc |
To be certified in LAMS, doctors from Vietnam, Thailand, the US, and other countries must complete training in South Korea. Photo: 365mc
After the US, Vietnam has been identified as the next strategic destination in 365mc's global expansion plan. The opening of a branch in Vietnam is expected soon, marking the arrival of a new generation of non-surgical fat reduction treatment. This will allow Vietnamese people to access advanced Korean fat reduction technologies locally, without traveling abroad.
365mc has also made a strategic investment in Raziel Therapeutics, with support from Yozma Group, a renowned Israeli investment fund specializing in connecting promising companies with international markets.
"With a solid foundation of expertise, an expanding global network, and a commitment to technological innovation, 365mc is progressively establishing itself as a leader in non-invasive fat reduction treatment in Asia and globally," a company representative stated.
Nhu Y